First Time Loading...
S

Second Sight Medical Products Inc
NASDAQ:EYES

Watchlist Manager
Second Sight Medical Products Inc
NASDAQ:EYES
Watchlist
Price: 4.14 USD -5.05%
Updated: May 6, 2024

Second Sight Medical Products Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Second Sight Medical Products Inc
Cash from Operating Activities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
Second Sight Medical Products Inc
NASDAQ:EYES
Cash from Operating Activities
-$18.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash from Operating Activities
$3.4B
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Cash from Operating Activities
$2.5B
CAGR 3-Years
10%
CAGR 5-Years
40%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Cash from Operating Activities
$3.5B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Cash from Operating Activities
$7.3B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Operating Activities
$1.7B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
8%

See Also

What is Second Sight Medical Products Inc's Cash from Operating Activities?
Cash from Operating Activities
-9.2m USD

Based on the financial report for Dec 31, 2021, Second Sight Medical Products Inc's Cash from Operating Activities amounts to -9.2m USD.

What is Second Sight Medical Products Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
45%

Over the last year, the Cash from Operating Activities growth was 45%.